The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase
André Holdfeldt(University of Gothenburg), Henrik Franzyk(University of Copenhagen), Christina Nielsen(University of Copenhagen), Cláes Dahlgren(University of Gothenburg), Anna Karlsson(Chalmers University of Technology), Sarah Line Skovbakke(University of Copenhagen), Camilla Josephine Larsen, Iris Perez-Gassol(University of Copenhagen), Ji Ming Wang(Frederick National Laboratory for Cancer Research), Huamei Forsman(Harvard University), Malene Winther(University of Gothenburg), Michael Gabl(University of Gothenburg)
Cited by 18
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244